Mozart Therapeutics

IN THE PRESS

Pharm Country

KUBTEC® Launches MOZART iQ® - A Next Generation 3D Margin Management System for Breast Surgery

May 11, 2023

·

3 min read

BioForest

Mozart Therapeutics to Present on Novel CD8 T Cell Network at the 2022 Digestive Disease Week® (DDW) Conference

May 18, 2022

·

2 min read

BioForest

Mozart Therapeutics Presents Data at IMMUNOLOGYTM 2022 Highlighting Novel CD8 Treg Network in Celiac Disease and Other Autoimmune Diseases

May 10, 2022

·

2 min read

Business

Mozart Therapeutics Announces Appointment of Jan Beck as Chief Operating Officer

March 21, 2022

·

2 min read

Business

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases

October 26, 2021

·

4 min read

Pharm Country

New Study Indicates that KUBTEC’s Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50%

September 23, 2020

·

3 min read

JOBS